Pas encore membre de TradeKey.com? Inscrivez-vous pour vous connecter avec 9 millions d'importateurs et exportateurs.
Rejoignez-le maintenant c'est gratuit |
BOOK A CALL
Book Call On Your Favorite Time

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us


Shanghai Yudiao Chemistry Technology Co., Ltd

Building A, NO.688,Qiushi Road,Jinshan District,Shanghai,shanghai,China China

Membre gratuit
Contacter maintenant
Voir le numéro de téléphone
Voir le numéro de mobile
Accueil Société Shanghai Yudiao Chemistry Technology Co., Ltd Offres de vente

Offres de vente: 17

Sell CAS# 319460-85-0
Sell CAS# 319460-85-0

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma

Contact Now
1H-Indazole, 3-iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-
1H-Indazole, 3-iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1
(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
Sell cas# 86230-76-8
Sell Cas# 86230-76-8

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
Sell cas# 886230-77-9
Sell Cas# 886230-77-9

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
Sell  CAS# 885126-35-2
Sell CAS# 885126-35-2

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
Sell cas# 20054-45-9
Sell Cas# 20054-45-9

Axitinib is an investigational drug being developed by Pfizer for treating advanced renal cell carcinoma (ARCC

Contact Now
Sell CAS# 125743-63-7
Sell CAS# 125743-63-7

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant hum

Contact Now
Sell cas# 1143459-92-0
Sell Cas# 1143459-92-0

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant hum

Contact Now
Sell cas#1048007-94-8
Sell Cas#1048007-94-8

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant hum

Contact Now
masitinib intermediate
Masitinib Intermediate

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant hum

Contact Now
Masitinib
Masitinib

In vitro, masitinib had greater activity and selectivity against KIT than imatinib, inhibiting recombinant hum

Contact Now
bendamustine hydrochloride
Bendamustine Hydrochloride

Bendamustine was first synthesized in 1963 by Ozegowski and Krebs in East Germany (the former German Democrati

Contact Now
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate
(S)-tert-butyl 3-oxo-1-phenylpropylcarbamate

A panel of four CCR5 monoclonal antibodies (mAbs) recognizing different epitopes on CCR5 was examined in CCR5-

Contact Now
Sell cas# 888504-28-7
Sell Cas# 888504-28-7

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically

Contact Now
2-Amino-2-methylpropionitrile
2-Amino-2-methylpropionitrile

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically

Contact Now
Sell  raltegravir(K salt)
Sell Raltegravir(K Salt)

Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically

Contact Now

    Contacter ce vendeur

    To:
    Mr. James < Shanghai Yudiao Chemistry Technology Co., Ltd >
    Je veux savoir: